AU2016278939B2 - Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne - Google Patents

Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne Download PDF

Info

Publication number
AU2016278939B2
AU2016278939B2 AU2016278939A AU2016278939A AU2016278939B2 AU 2016278939 B2 AU2016278939 B2 AU 2016278939B2 AU 2016278939 A AU2016278939 A AU 2016278939A AU 2016278939 A AU2016278939 A AU 2016278939A AU 2016278939 B2 AU2016278939 B2 AU 2016278939B2
Authority
AU
Australia
Prior art keywords
vitamin
taurine
magnesium
acne
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016278939A
Other languages
English (en)
Other versions
AU2016278939A1 (en
Inventor
Margaret Jean Profet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2016278939A1 publication Critical patent/AU2016278939A1/en
Application granted granted Critical
Publication of AU2016278939B2 publication Critical patent/AU2016278939B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016278939A 2015-06-17 2016-06-10 Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne Ceased AU2016278939B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562180842P 2015-06-17 2015-06-17
US62/180,842 2015-06-17
PCT/US2016/037050 WO2016205089A1 (en) 2015-06-17 2016-06-10 Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Publications (2)

Publication Number Publication Date
AU2016278939A1 AU2016278939A1 (en) 2017-12-07
AU2016278939B2 true AU2016278939B2 (en) 2018-11-08

Family

ID=57546606

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016278939A Ceased AU2016278939B2 (en) 2015-06-17 2016-06-10 Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Country Status (9)

Country Link
US (2) US9795633B2 (enExample)
EP (1) EP3310366A4 (enExample)
JP (2) JP6657394B2 (enExample)
KR (2) KR20190137971A (enExample)
CN (1) CN107708708A (enExample)
AU (1) AU2016278939B2 (enExample)
CA (1) CA2987293C (enExample)
MX (1) MX365366B (enExample)
WO (1) WO2016205089A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9642877B1 (en) * 2016-01-06 2017-05-09 Kenneth O. Russell Method of administration of chromium and magnesium sulfate for treatment of acne
CA2987293C (en) * 2015-06-17 2020-11-03 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
CN107049890B (zh) * 2017-06-27 2020-04-03 广东芭薇生物科技股份有限公司 一种具有舒缓抗粉刺功效的护肤品
KR102310566B1 (ko) * 2018-05-21 2021-10-08 랩앤피플주식회사 여드름 완화 및 예방용 패치
WO2019225948A1 (ko) * 2018-05-21 2019-11-28 랩앤피플주식회사 여드름 완화 및 예방용 패치
KR102651395B1 (ko) * 2018-07-05 2024-03-26 랩앤피플주식회사 여드름 완화 및 예방용 화장품 조성물
EP3738588A1 (en) 2019-05-13 2020-11-18 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
CA3137407A1 (fr) 2019-05-16 2020-11-19 Synapharm Industrial Synthesis Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
ES2917623T3 (es) * 2019-05-16 2022-07-11 Synapharm Ind Synthesis Compuesto y composición para uso en el tratamiento del síndrome premenstrual y/o del trastorno disfórico premenstrual
WO2024118480A1 (en) * 2022-11-28 2024-06-06 Epiphany Biosciences Use of antiviral agents, composition of matter, combination preparations/agents to treat chronic diseases associated with epstein-barr virus and other human herpes viruses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US5962517A (en) * 1997-01-31 1999-10-05 Murad; Howard Pharmaceutical compositions and methods for treating acne

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
CN1126596A (zh) * 1995-01-11 1996-07-17 徐富中 一种治疗粉刺的制剂
US5776498A (en) 1995-11-06 1998-07-07 Nutrition 21 Magnesium taurate as an adjuvant to rapid thrombolytic therapy
US5582839A (en) 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
US6558656B2 (en) 2000-04-20 2003-05-06 Morris Mann Oral and topical compositions and methods related thereto in the treatment of acne
US20040039042A1 (en) 2002-08-23 2004-02-26 Fleming Thomas E. Method of transdermal drug delivery
US20040214891A1 (en) 2003-04-22 2004-10-28 Janusz Marcinkiewicz Method for inhibiting pathogenic bacteria and fungi growth and microbicidal composition
US20050008684A1 (en) 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
US7258875B2 (en) 2003-12-04 2007-08-21 Chiou Consulting, Inc. Compositions and methods for topical treatment of skin infection
EP1720515A1 (en) * 2004-03-02 2006-11-15 GIULIANI S.p.A. Composition for regulating the trophism of hair follicles and the cutaneous production of sebum and use thereof in androgenetic alopecia
US20060193922A1 (en) 2005-02-25 2006-08-31 Natalia Neikrug Compositions and methods for the treatment of acne
US7955610B2 (en) 2005-08-04 2011-06-07 National Science And Technology Development Agency Antimicrobial composition for topical application and a method thereof
AR062334A1 (es) 2006-08-11 2008-10-29 Panacea Biotec Ltd Particulas para suministrar ingredientes activos, proceso para hacerlas y composiciones de las mismas
JP2011528377A (ja) * 2008-07-17 2011-11-17 レヴィス，ジョージア 座瘡治療のための方法及び物質
PL2418945T3 (pl) * 2009-04-15 2019-05-31 Bmg Pharma S P A Kompozycje soli mineralnej - kwasu sulfonowego i sposoby ich stosowania
US20140121188A1 (en) 2009-10-02 2014-05-01 Foamix Ltd. Compositions for the improved treatment of acne and related disorders
KR20170018852A (ko) * 2014-07-01 2017-02-20 엔리케 샤콘 상처 치료를 위한 국소 조성물 및 방법
CA2987293C (en) * 2015-06-17 2020-11-03 Margaret Jean Profet Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545977A (en) * 1985-01-11 1985-10-08 G. D. Searle & Co. Compositions and methods for treating severe acne with isotretinoin
US5962517A (en) * 1997-01-31 1999-10-05 Murad; Howard Pharmaceutical compositions and methods for treating acne

Also Published As

Publication number Publication date
JP2018517787A (ja) 2018-07-05
US10342823B2 (en) 2019-07-09
JP6657394B2 (ja) 2020-03-04
KR20190137971A (ko) 2019-12-11
JP2020073587A (ja) 2020-05-14
CA2987293C (en) 2020-11-03
KR102055492B1 (ko) 2019-12-12
MX2017015012A (es) 2018-08-15
US9795633B2 (en) 2017-10-24
US20180036340A1 (en) 2018-02-08
KR20180004202A (ko) 2018-01-10
MX365366B (es) 2019-05-30
US20160367596A1 (en) 2016-12-22
EP3310366A1 (en) 2018-04-25
WO2016205089A1 (en) 2016-12-22
AU2016278939A1 (en) 2017-12-07
CA2987293A1 (en) 2016-12-22
EP3310366A4 (en) 2019-01-02
CN107708708A (zh) 2018-02-16

Similar Documents

Publication Publication Date Title
AU2016278939B2 (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
JP5388568B2 (ja) ざ瘡を治療するための組成物及び方法
US20070292493A1 (en) Pharmaceutical composition and method for the transdermal delivery of calcium
JP2002543106A (ja) 抗悪心組成物および方法
CA2554860A1 (en) Pharmaceutical composition and method for the transdermal delivery of magnesium
US20150216823A1 (en) Compositions for the treatment of migraine headaches and methods thereof
US20110244057A1 (en) Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
US10702493B2 (en) Methods and compositions for the treatment of acne
US20110256237A1 (en) Methods and compositions for treating acne vulgaris and acne rosacea
JP4553552B2 (ja) 生体リズム応用キット
EP3738588A1 (en) Topical and oral formulations comprising taurine and magnesium for use in the treatment of rosacea
US20190262390A1 (en) Topical and oral formulations comprising taurine and magnesium for the treatment of rosacea
US20130059813A1 (en) Treatment of dermatological conditions
Statsenko et al. Isotretinoin is the gold standard for acne therapy. Treating severe acne

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired